Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |